Literature DB >> 5471456

Localization of d- and l-methadone after intraventricular injection into rat brains.

N A Ingoglia, V P Dole.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5471456

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  8 in total

Review 1.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

2.  Overview and historical perspective of four papers presented on research related to the endogenous opioid system.

Authors:  Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2010-04-18       Impact factor: 4.492

3.  Assessment of drug-drug interactions between daclatasvir and methadone or buprenorphine-naloxone.

Authors:  T Garimella; R Wang; W-L Luo; P Wastall; H Kandoussi; M DeMicco; R D Bruce; C Hwang; R Bertz; M Bifano
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

Review 4.  Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology.

Authors:  Jennifer L Whistler
Journal:  Drug Alcohol Depend       Date:  2012-01-09       Impact factor: 4.492

Review 5.  Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases.

Authors:  M J Kreek
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

Review 6.  Methadone: a new old drug with promises and pitfalls.

Authors:  Jodie A Trafton; Abhinav Ramani
Journal:  Curr Pain Headache Rep       Date:  2009-02

7.  Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain.

Authors:  A Goldstein; L I Lowney; B K Pal
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

8.  Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid-dependent, human immunodeficiency virus seronegative participants.

Authors:  Katy Moore; Mindy Magee; Heather Sevinsky; Ming Chang; Susan Lubin; Elsa Myers; Peter Ackerman; Cyril Llamoso
Journal:  Br J Clin Pharmacol       Date:  2019-06-05       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.